The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FOLFIRINOX in the real world setting: The multicentric experience of six Canadian institutions.
Carl Amireault
No relevant relationships to disclose
Jean-Pierre M. Ayoub
No relevant relationships to disclose
Julie Beaudet
No relevant relationships to disclose
Guylaine Gaudet
No relevant relationships to disclose
Richard Letourneau
No relevant relationships to disclose
Rasmy Loungnarath
No relevant relationships to disclose
Nicolas Raymond
No relevant relationships to disclose
Mustapha Ali Tehfe
Consultant or Advisory Role - Sanofi (U)
Research Funding - Sanofi
Francine Aubin
Consultant or Advisory Role - Sanofi (U)